Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIPC in Open AAA Repair
NCT02570464Completed
- Sponsor
- Rouen University Hospital
- Start
- Mar 2012
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Tumor Necrosis Factor alpha at 24 hours. Started Mar 2012; status: completed.
Beyond the preview
Go deeper on NCT02570464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02570464.